We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Partners With Accent for Novel Cancer Therapeutics
AstraZeneca Partners With Accent for Novel Cancer Therapeutics
AstraZeneca and Accent Therapeutics have teamed up to develop cancer therapies using RNA-modifying proteins in a deal potentially worth more than $1 billion for the small Massachusetts-based startup.